{"id":"https://openalex.org/W2014471935","doi":"https://doi.org/10.1002/syn.21531","title":"Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity","display_name":"Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity","publication_year":2011,"publication_date":"2011-12-28","ids":{"openalex":"https://openalex.org/W2014471935","doi":"https://doi.org/10.1002/syn.21531","mag":"2014471935","pmid":"https://pubmed.ncbi.nlm.nih.gov/22213370"},"language":"en","primary_location":{"id":"doi:10.1002/syn.21531","doi":"https://doi.org/10.1002/syn.21531","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.21531","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053954553","display_name":"Krystyna Go\u0142embiowska","orcid":"https://orcid.org/0000-0002-5018-1394","observed_orcids":["https://orcid.org/0000-0002-5018-1394"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Krystyna Golembiowska","raw_affiliation_strings":["Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101669339","display_name":"Magdalena Kowalska","orcid":"https://orcid.org/0000-0001-7950-5543","observed_orcids":["https://orcid.org/0000-0001-7950-5543"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Kowalska","raw_affiliation_strings":["Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110261041","display_name":"Frank P. Bymaster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Frank P. Bymaster","raw_affiliation_strings":["Euthymics Biosciences Inc., 43 Thorndike St. Suite 1-3, Cambridge, Massachusetts 02141"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Euthymics Biosciences Inc., 43 Thorndike St. Suite 1-3, Cambridge, Massachusetts 02141","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110261041"],"corresponding_institution_ids":[],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":3.8071,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.92410545,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"66","issue":"5","first_page":"435","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7627000212669373,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7627000212669373,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.22689999639987946,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-reuptake-inhibitors","display_name":"triple reuptake inhibitors","score":0.875},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.6290000081062317},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8289999961853027},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.5220000147819519},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":1.0},{"id":"https://openalex.org/keywords/monoamine-metabolism","display_name":"monoamine metabolism","score":0.5690000057220459},{"id":"https://openalex.org/keywords/5-hydroxyindoleacetic-acid","display_name":"5-hydroxyindoleacetic acid","score":0.925000011920929},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dopac","display_name":"DOPAC","score":0.9419999718666077},{"id":"https://openalex.org/keywords/monoamine-uptake-inhibition","display_name":"monoamine uptake inhibition","score":0.8650000095367432},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.75},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.9459999799728394},{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.8759999871253967},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9539999961853027},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.824999988079071},{"id":"https://openalex.org/keywords/brain-regions","display_name":"brain regions","score":0.3790000081062317}],"concepts":[{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.804794192314148},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.7652509212493896},{"id":"https://openalex.org/C2775841634","wikidata":"https://www.wikidata.org/wiki/Q903566","display_name":"Homovanillic acid","level":4,"score":0.7448028326034546},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.7316914796829224},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.7270817756652832},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6564378142356873},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.6287193298339844},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.558400571346283},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5431036949157715},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5229794979095459},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5065902471542358},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.4731655716896057},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.4502134919166565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3809460401535034},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3752940893173218},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24661961197853088},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18884849548339844},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.147474467754364},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12740379571914673},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.07559984922409058}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001372","descriptor_name":"Aza Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006719","descriptor_name":"Homovanillic Acid","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006897","descriptor_name":"Hydroxyindoleacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015102","descriptor_name":"3,4-Dihydroxyphenylacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/syn.21531","doi":"https://doi.org/10.1002/syn.21531","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.21531","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmid:22213370","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22213370","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":77,"referenced_works":["https://openalex.org/W26268295","https://openalex.org/W51209413","https://openalex.org/W78856436","https://openalex.org/W100865822","https://openalex.org/W105240579","https://openalex.org/W124759840","https://openalex.org/W138509012","https://openalex.org/W144082570","https://openalex.org/W251565955","https://openalex.org/W1604375471","https://openalex.org/W1865055600","https://openalex.org/W1939710647","https://openalex.org/W1965716206","https://openalex.org/W1971669832","https://openalex.org/W1973988192","https://openalex.org/W1976410377","https://openalex.org/W1979420282","https://openalex.org/W1981648956","https://openalex.org/W1985193354","https://openalex.org/W1992103170","https://openalex.org/W1992164809","https://openalex.org/W1995731066","https://openalex.org/W1997245512","https://openalex.org/W2002834809","https://openalex.org/W2005565158","https://openalex.org/W2014203063","https://openalex.org/W2017407904","https://openalex.org/W2019823288","https://openalex.org/W2021999429","https://openalex.org/W2023504580","https://openalex.org/W2023946047","https://openalex.org/W2026784040","https://openalex.org/W2032542268","https://openalex.org/W2037664489","https://openalex.org/W2040295810","https://openalex.org/W2040513075","https://openalex.org/W2042903064","https://openalex.org/W2044907318","https://openalex.org/W2045894239","https://openalex.org/W2046064455","https://openalex.org/W2046658074","https://openalex.org/W2047494050","https://openalex.org/W2048595403","https://openalex.org/W2048829461","https://openalex.org/W2048924884","https://openalex.org/W2050971274","https://openalex.org/W2051141776","https://openalex.org/W2052080148","https://openalex.org/W2057760214","https://openalex.org/W2062684328","https://openalex.org/W2064611362","https://openalex.org/W2067998521","https://openalex.org/W2071677128","https://openalex.org/W2078752612","https://openalex.org/W2079311820","https://openalex.org/W2080402976","https://openalex.org/W2089299823","https://openalex.org/W2110653806","https://openalex.org/W2114746853","https://openalex.org/W2118336207","https://openalex.org/W2122592499","https://openalex.org/W2127294790","https://openalex.org/W2131991903","https://openalex.org/W2135665329","https://openalex.org/W2136137449","https://openalex.org/W2137296158","https://openalex.org/W2144859687","https://openalex.org/W2145657633","https://openalex.org/W2145926098","https://openalex.org/W2147992450","https://openalex.org/W2149402043","https://openalex.org/W2150355913","https://openalex.org/W2151137320","https://openalex.org/W2154134749","https://openalex.org/W2436673908","https://openalex.org/W2556209728","https://openalex.org/W2588909565"],"related_works":["https://openalex.org/W1953726914","https://openalex.org/W6888599342","https://openalex.org/W2014799344","https://openalex.org/W3031941142","https://openalex.org/W2097053175","https://openalex.org/W1981648956","https://openalex.org/W2016739757","https://openalex.org/W2314130842","https://openalex.org/W2065242435","https://openalex.org/W2055244662"],"abstract_inverted_index":{"Major":[0],"depressive":[1],"disorder":[2],"is":[3,10],"a":[4,20,51,178],"prevalent":[5],"disease,":[6],"and":[7,34,70,92,116,124,142,155,158,199,227],"current":[8],"pharmacotherapy":[9],"considered":[11],"to":[12,32],"be":[13],"inadequate.":[14],"It":[15],"has":[16],"been":[17],"hypothesized":[18],"that":[19,25,237],"triple":[21],"reuptake":[22],"inhibitor":[23],"(TRI)":[24],"activates":[26],"dopamine":[27],"(DA)":[28],"neurotransmission":[29],"in":[30,40,73,81,126,137,165,209,229],"addition":[31],"serotonin":[33],"norepinephrine":[35],"(NE)":[36],"circuitries":[37],"may":[38,239],"result":[39],"enhanced":[41],"antidepressant":[42,242],"effects.":[43],"Here,":[44],"we":[45],"investigated":[46,78,107],"the":[47,80,103,138,149,210],"pharmacological":[48],"effects":[49,59,86],"of":[50,60,68,87,101,110,121,132,148,151,185,196,224],"serotonin-preferring":[52],"TRI-amitifadine":[53],"(EB-1010,":[54],"formerly":[55],"DOV":[56],"21947).":[57],"The":[58,85,129,145,182,222],"amitifadine":[61,88,186,192,205,238],"(10":[62],"mg/kg":[63],"ip.)":[64],"on":[65,89],"extracellular":[66,119,130,146,194],"concentrations":[67,120,131,147,195],"monoamines":[69],"their":[71],"metabolites":[72,150],"rat":[74,230],"brain":[75,166,231],"regions":[76,232],"were":[77,95,134,161],"using":[79],"vivo":[82],"microdialysis":[83],"technique.":[84],"locomotor":[90,172,217],"activity":[91,173],"stereotyped":[93],"behavior":[94],"also":[96,135,162],"evaluated.":[97],"A":[98],"major":[99],"metabolite":[100,184],"amitifadine,":[102],"2-lactam":[104],"compound,":[105],"was":[106],"for":[108],"inhibition":[109],"monoamine":[111,189],"uptake":[112],"processes.":[113],"Amitifadine":[114,168],"markedly":[115,163],"persistently":[117],"increased":[118,136,193,207],"serotonin,":[122,152,197,225],"NE,":[123,198,226],"DA":[125,133,208,228],"prefrontal":[127],"cortex.":[128],"DA-rich":[139],"areas":[140],"striatum":[141],"nucleus":[143,211],"accumbens.":[144],"5-hydroxyindoleacetic":[153],"acid,":[154,160],"DA,":[156,200],"3,4-dihydroxyphenylacetic":[157],"homovanillic":[159],"decreased":[164],"regions.":[167],"did":[169,214],"not":[170,215],"increase":[171],"or":[174,219],"stereotypical":[175,220],"behaviors":[176],"over":[177],"broad":[179],"dose":[180],"range.":[181],"lactam":[183],"weakly":[187],"inhibited":[188],"uptake.":[190],"Thus,":[191],"consistent":[201],"with":[202,234],"TRI.":[203],"Although":[204],"significantly":[206],"accumbens,":[212],"it":[213],"induce":[216],"hyperactivity":[218],"behaviors.":[221],"enhancement":[223],"associated":[233],"depression":[235],"suggest":[236],"have":[240],"novel":[241],"activity.":[243]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}